Skip to content

Effects of non-surgical periodontal treatment on clinical, immunological responses and metabolic control in type 2 diabetic patients: a randomized study

Relationship between periodontal inflammaton and systemic diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001062
Enrollment
Unknown
Registered
2010-10-27
Start date
2008-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic parients with periodontitis

Interventions

treatment group 1:non-surgical periodontal treatment at baseline and additional subgingival debridement at follow-up
treatment group 2:non-surgical periodontal treatment at baseline plus supragingival prophylaxis at follow-up
control group:no intervention measure

Sponsors

Peking University, Guangdong Provincial Stomatological Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. diagnosis of type 2 diabetes mellitus (Engebretson et al., 2007) for more than 1 year with no change in diabetic treatment plan in the past 2 months, and without major diabetic complications such as coronary heart disease; 2. with a clinical diagnosis of chronic periodontitis according to the criteria of the American Academy of Periodontology (Wiebe and Putnins, 2000), with presence of >=16 teeth in the mouth.

Exclusion criteria

Exclusion criteria: 1. presence of systemic diseases other than DM that influence the course of periodontal disease; 2. active infection other than periodontitis or received periodontal treatment in the previous 12 months; 3. systemic antibiotic administration within the latest 3 months; 3. pregnancy or lactation; 5. refusal of informed consent.

Design outcomes

Primary

MeasureTime frame
HbA1c;

Secondary

MeasureTime frame
TNF-alpha;plaque index;low-density lipoprotein cholesterol;gingival recession;high-density lipoprotein cholesterol;total cholesterol;fasting plasma glucose;triglycerides;clinical attachment level;probing depth;bleeding on probing;hsCRP;

Countries

China

Contacts

Public ContactJincai Zhang
Jincaizhang@live.net+86 20 8441 3940

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026